BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16970396)

  • 1. Virtual screening for aryl hydrocarbon receptor binding prediction.
    Lo Piparo E; Koehler K; Chana A; Benfenati E
    J Med Chem; 2006 Sep; 49(19):5702-9. PubMed ID: 16970396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking and 3D-QSAR studies on the Ah receptor binding affinities of polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs).
    Li F; Li X; Liu X; Zhang L; You L; Zhao J; Wu H
    Environ Toxicol Pharmacol; 2011 Nov; 32(3):478-85. PubMed ID: 22004969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimode ligand binding in receptor site modeling: implementation in CoMFA.
    Lukacova V; Balaz S
    J Chem Inf Comput Sci; 2003; 43(6):2093-105. PubMed ID: 14632461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical study of the quantitative structure-activity relationships for the toxicity of dibenzo-p-dioxins.
    Zhao YY; Tao FM; Zeng EY
    Chemosphere; 2008 Aug; 73(1):86-91. PubMed ID: 18589475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of ordinal CoMFA by ridge logistic partial least squares.
    Ohgaru T; Shimizu R; Okamoto K; Kawashita N; Kawase M; Shirakuni Y; Nishikiori R; Takagi T
    J Chem Inf Model; 2008 Apr; 48(4):910-7. PubMed ID: 18338844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human aryl-hydrocarbon receptor and its interaction with dioxin and physiological ligands investigated by molecular modelling and docking simulations.
    Salzano M; Marabotti A; Milanesi L; Facchiano A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):176-81. PubMed ID: 21871440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for protein-ligand binding affinity prediction and the related descriptors exploration.
    Li S; Xi L; Wang C; Li J; Lei B; Liu H; Yao X
    J Comput Chem; 2009 Apr; 30(6):900-9. PubMed ID: 18785151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface descriptors for protein-ligand affinity prediction.
    Zamora I; Oprea T; Cruciani G; Pastor M; Ungell AL
    J Med Chem; 2003 Jan; 46(1):25-33. PubMed ID: 12502357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA.
    Ashek A; Lee C; Park H; Cho SJ
    Chemosphere; 2006 Oct; 65(3):521-9. PubMed ID: 16487571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.
    Honorio KM; Garratt RC; Andricopulo AD
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3119-25. PubMed ID: 15893927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case.
    Yasuo K; Yamaotsu N; Gouda H; Tsujishita H; Hirono S
    J Chem Inf Model; 2009 Apr; 49(4):853-64. PubMed ID: 19391630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A(3) adenosine receptor antagonists.
    Moro S; Bacilieri M; Cacciari B; Spalluto G
    J Med Chem; 2005 Sep; 48(18):5698-704. PubMed ID: 16134938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of receptor-mediated environmental toxic phenomena-application to endocrine disruption.
    Lill MA; Dobler M; Vedani A
    SAR QSAR Environ Res; 2005; 16(1-2):149-69. PubMed ID: 15844448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR study of 20 (S)-camptothecin analogs.
    Lu AJ; Zhang ZS; Zheng MY; Zou HJ; Luo XM; Jiang HL
    Acta Pharmacol Sin; 2007 Feb; 28(2):307-14. PubMed ID: 17241535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
    Larsen SB; Jørgensen FS; Olsen L
    J Chem Inf Model; 2008 Jan; 48(1):233-41. PubMed ID: 18092768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.